Non-small cell lung cancer staging

The staging process combines information from scans, examination, and sometimes a biopsy. Imaging can show the primary tumour, lymph nodes in the chest, and areas outside the lung that need checking. A tissue sample confirms the cancer type and may provide molecular information that affects treatment selection.

Stages are commonly grouped from an early, localised cancer through cancers involving nearby structures or nodes to cancer that has spread farther away. The stage is a summary of the disease at assessment; it does not describe your identity or predict exactly how one person will respond.

Ask which tests established the stage and whether any result is still pending. Your care team may discuss surgery such as lung lobectomy, focused radiation, or medicines such as immunotherapy or targeted therapy. Some people receive more than one approach, either before surgery, after surgery, or to control disease that cannot be removed safely.

Keep copies of scan reports and pathology results, and tell the team about breathing problems, other illnesses, medicines, and your practical priorities. Those details help shape a plan that is medically suitable and workable for you.

Contact emergency services for severe breathlessness, coughing up substantial blood, sudden weakness, fainting, new confusion, or chest pain that is intense or accompanied by sweating. During treatment, report fever, rapidly worsening breathing, or a sudden change in alertness promptly because these may need immediate assessment.

What is the clinical stage and what evidence supports it? Have the lymph nodes or distant areas been assessed? Is molecular testing needed? What treatment sequence do you recommend, and what would make the plan change?